Amelioration with vessel dilator of acute tubular necrosis and renal failure established for 2 days

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 5 47-5, 2000, Pages

  Clark, Linda C ^a   Farghaly, Hanan ^a   Saba, Sabiha R ^a   Vesely, David L ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Atrial natriuretic peptides; Blood urea nitrogen; Diuresis; Serum creatinine; Transthoracic echocardiography

Indexed keywords

ATRIAL NATRIURETIC FACTOR; PEPTIDE HORMONE; UNCLASSIFIED DRUG; VESSEL DILATOR;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSTHORACIC ECHOCARDIOGRAPHY; UREA NITROGEN BLOOD LEVEL; VASODILATATION;

EID: 0034082202     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.5.h1555     Document Type: Article

References (30)

1. Ackerman BH, Overton RM, McCormick MT, Schocken DD, and Vesely DL. Disposition of vessel dilator and long-acting natriuretic peptide in healthy humans following a one-hour infusion. J Pharmacol Exp Ther 282: 603-608, 1997.
2. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BRC, Conger JD, and Sayegh MH. Anaritide in acute tubular necrosis. N Engl J Med 336: 828-834, 1997.
3. Brezis M, Rosen S, Silva P, and Epstein F. Renal ischemia: a new perspective. Kidney Int 26: 375-383, 1984.
4. +-ATPase of the atrial natriuretic peptides. Endocrinology 136: 2033-2039, 1995.
5. Conger JD, Falk SA, Yuan BH, and Schrier RW. Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int 35: 1126-1132, 1989.
6. 2. J Clin Invest 89: 1411-1417, 1992.
7. Habibullah AA, Villarreal D, Freeman RH, Dietz JR, Vesely DL, and Simmons JC. Infusion of atrial natriuretic factor prohormone peptides in dogs with experimental heart failure. Clin Exp Pharmacol Physiol 22: 130-135, 1995.
8. Karlberg L, Norlen B, Tjtey G, and Wolgast M. Impaired medullary circulation in postischemic acute renal failure. Acta Physiol Scand 118: 11-17, 1983.
9. Kentsch M, Drummer C, Gerzer R, and Muller-Esch G. Severe hypotension and bradycardia after continuous intravenous infusion of urodilatin (ANP 95-126) in a patient with congestive heart failure. Eur J Clin Invest 25: 281-283, 1995.
10. Kjellstrand MC and Solez K. Treatment of acute renal failure. Diseases of the Kidney (5th ed), edited by Schrier, R. W. and C. W. Gottschalk. Boston, MA: Little Brown, 1993, p. 1371-1407.
11. Klausner JM, Paterson IS, Goldman G, Kobzick L, Rodzen C, Lawrence R, Valeri CR, Shepro D, and Hechtman HB. Post-ischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol Renal Fluid Electrolyte Physiol 256: F794-F802, 1989.
12. Lieberthal W, Sheridan AM, and Valeri CR. Protective effect of atrial natriuretic factor and mannitol following renal ischemia. Am J Physiol Renal Fluid Electrolyte Physiol 258: F1266-F1272, 1990.
13. Loghman-Adham M. Role of phosphate retention in the progression of renal failure. J Lab Clin Med 122: 16-26, 1993.
14. 2-terminus are natriuretic and/or kaliuretic. Am J Physiol Renal Fluid Electrolyte Physiol 258: F1401-F1408, 1990.
15. 1 in the dog with norepinephrine-induced acute renal failure. Invest Radiol 10: 284-299, 1975.
16. Nakamoto M, Shapiro JI, Shanley PF, Chan L, and Schrier RW. In vitro and in vivo protective effects of atriopeptin III on ischemic acute renal failure. J Clin Invest 80: 698-705, 1987.
17. Poulos JE, Gower WR Jr, Sullebarger JT, Fontanet HL, and Vesely DL. Congestive heart failure: Increased cardiac and extracardiac atrial natriuretic peptide gene expression. Cardiovasc Res 32: 909-919, 1996.
18. Saba SR, Ramirez G, and Vesely DL. Immunocytochemical localization of proANF 1-30, proANF 31-67, atrial natriuretic factor and urodilatin in the human kidney. Am J Nephrol 13:85-93, 1993.
19. Shaw SG, Weidmann P, Hodler J, Zimmermann A, and Paternostro A. Atrial natriuretic peptide protects against ischemic renal failure in the rat. J Clin Invest 80: 1232-1237, 1987.
20. Shaw S, Weidmann P, and Zimmermann A. Urodilatin, not nitroprusside, combined with dopamine reverses ischemic acute renal failure. Kidney Int 42: 1153-1159, 1992.
21. 1 on ischemia-induced acute renal failure in dogs. Surgery 9: 45-52, 1985.
22. Totsune K, Mackenzie HS, Totsune H, Troy JL, Lytton J, and Brenner BM. Upregulation of atrial natriuretic peptide gene expression in remnant kidney of rats with reduced renal mass. J Am Soc Nephrol 9: 1613-1617, 1998.
23. Vesely DL. Atrial Natriuretic Hormones. Englewood Cliffs, NJ: Prentice Hall, 1992, p. 1-256.
24. Vesely DL, Dietz JR, Parks JR, Baig M, McCormick MT, Cintron G, and Schocken DD. Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure. Circulation 98: 323-329, 1998.
25. Vesely DL, Douglass MA, Dietz JR, Giordano AT, McCormick MT, Rodriguez-Paz G, and Schocken DD. Negative feedback of atrial natriuretic peptides. J Clin Endocrinol Metab 78: 1128-1134, 1994.
26. Vesely DL, Douglass MA, Dietz JR, Gower WR Jr, McCormick MT, Rodriguez-Paz G, and Schocken DD. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce a diuresis, natriuresis, and/or kaliuresis in humans. Circulation 90: 1129-1140, 1994.
27. 2-induced acute tubular necrosis. J Histochem Cytochem 36: 1103-1108, 1988.
28. 2] in glycerol-induced acute renal failure in rats. Clin Sci Mol Med 55: 505-507, 1978.
29. Winters CJ and Vesely DL. Change in plasma immunoreactive N-terminus, C-terminus, and 4000 dalton mid portion of atrial natriuretic factor prohormone with hemodialysis. Nephron 58: 17-22, 1991.
30. Winters CJ, Sallman AL, Baker BJ, Meadows J, Rico DM, and Vesely DL. The N-terminus and a 4000 molecular weight peptide from the mid portion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Circulation 80: 438-449, 1989.